Canada Markets closed

Theralase Technologies Inc. (TLT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1500+0.0050 (+3.45%)
At close: 3:57PM EDT
Sign in to post a message.
  • E
    Elijah
    Ive has this #$%$ for almost 15 years. Juuuuunk!!
  • I
    InTheBank
    Excellent news

    TORONTO, ON / ACCESSWIRE / August 12, 2020 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDC") and associated drug formulations, announced today that three out of four of its Canadian clinical study sites have re-commenced new patient enrollment and treatment in the Company's Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") clinical study ("Study II").

    On a go forward basis, all future and existing patients to be enrolled and treated (initial and second treatment) in Study II will be treated using the Study II treatment optimizations as communicated via press release on July 30, 2020, specifically:
    1 Bladder volume calculation
    2 Study drug volume calculation
    3 Study device volume calculation
    4 Study device treatment time
    Four of the patients previously treated are awaiting second treatment subject to the clinical study site operating room availability. One additional patient is undergoing additional assessments prior to proceeding to second treatment.
    The Company is in advanced discussions to launch a number of US based clinical study sites, subject to the United States economy recovering from the COVID-19 pandemic.
    The US based Trial Management Organization ("TMO") could potentially launch 4 clinical study sites in 4Q2020 and commence Study II patient enrollment and treatment in 1Q2021.
  • I
    InTheBank
    Wow
    Theralase is going in the COVID arena. This should be very interesting.
  • J
    Jose Miquel
    3 new jobs were posted in the last 6 days, according to Linkedin, that sees Theralase hiring for a PR coordinator, Marketing coordinator & investor relations coordinator. VERY exciting!! Maybe now people in the real world may actually hear about the wonderful things this team is doing here. Good good things happening here
  • B
    Barry Klein
    New information. Theralase has successfully completed the 1b study and it has been ended early which BTW is very rare. This is incredibly positive news. glta
  • J
    Joel H
    I have been in Theralase for a couple of years and the results have been exciting. Looking forward to getting approved for not only bladder cancer but for other types as well. I am long and will continue to be long on this one
  • h
    huyendang
    Good news today. Thos is what people want to know last couple weeks.
  • K
    Karm
    Going to go past .80cents come February.
  • v
    victor
    This stock should be at 0.50 - 0.70 range with that latest news. 0.20c is a funny history now.
  • s
    sunny
    TORONTO, ON / ACCESSWIRE / January 31, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic C
    TORONTO, ON / ACCESSWIRE / January 31, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic C
    finance.yahoo.com
  • p
    patience2win
    Theralase Featured: Bloomberg Canada B-tv
    Sat July 28th at 8pm. See video link.
    http://www.b-tv.com/theralase-technologies-feature-ep-329/
    An innovative medical technology for bladder cancer treatment. Theralase® Technologies Inc. is a biopharmaceutical company headquartered in Toronto, Canada focused on the design, development, manufacturing, and sale of patented laser technology platf
    An innovative medical technology for bladder cancer treatment. Theralase® Technologies Inc. is a biopharmaceutical company headquartered in Toronto, Canada focused on the design, development, manufacturing, and sale of patented laser technology platf
    www.b-tv.com
  • h
    huyendang
    lets get over next week. 2 news coming on 24 to 28...cheers
  • m
    mark
    This stock if it performs as a better alternative to BCG will be on fire. BCG is gold standard for bladder cancer treatment but is in short supply, requires a series of treatments and can’t be used for some people due to side effects.
  • K
    Karm
    The other patient are going to be introduced and theyre status
  • h
    hendry
    anyone see the news about this law sued for defamatory comments on yahoo news?
  • G
    Gabriel
    Hi theralase guys and gals,
    If you want to see some action in conversations go to stockhouse.com, select theralase and click on bullboard.
    You will find a lot of due diligence by a group of smart guys.
    Theralase train is leaving the station !
  • A
    ALL4DAMONEY
    Well, what did shareholders expect? Minimizing by management continues! No Halt, announced a share price capping series of pps for over a 100 million dollars,, 80 to 90 % dilution on the way, could have announcdd result of p6 before pp announcement, but they didnt. They want the pp as low as possible to give the company over to new investors as cheaply as possible. The biggest give away i have seen. If this company truly is what it looks like, long shareholders have been royally hosed. Thank you management for not getting a deal, not getting a jv, and instead going for the worst option available, giving the company to new investors for a song and dance.
  • h
    huyendang
    tomo or wed....news coming
  • j
    jonny
    Anyone thinking of jumping in today ?
  • T
    T.A.
    Ah, finally some good news and some movement on this stock. Been in the red with this thing for a few years now. Hope the patience pays off. Looks like they are doing some good work.